Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

4D Molecular Therapeutics (FDMT) Revenue: 2019-2024

Historic Revenue for 4D Molecular Therapeutics (FDMT) over the last 6 years, with Dec 2024 value amounting to $37,000.

  • 4D Molecular Therapeutics' Revenue rose 2900.00% to $90,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $120,000, marking a year-over-year increase of 605.88%. This contributed to the annual value of $37,000 for FY2024, which is 99.82% down from last year.
  • As of FY2024, 4D Molecular Therapeutics' Revenue stood at $37,000, which was down 99.82% from $20.7 million recorded in FY2023.
  • 4D Molecular Therapeutics' 5-year Revenue high stood at $20.7 million for FY2023, and its period low was $37,000 during FY2024.
  • Moreover, its 3-year median value for Revenue was $3.1 million (2022), whereas its average is $8.0 million.
  • In the last 5 years, 4D Molecular Therapeutics' Revenue soared by 562.29% in 2023 and then crashed by 99.82% in 2024.
  • Over the past 5 years, 4D Molecular Therapeutics' Revenue (Yearly) stood at $13.6 million in 2020, then skyrocketed by 32.52% to $18.0 million in 2021, then crashed by 82.65% to $3.1 million in 2022, then surged by 562.29% to $20.7 million in 2023, then crashed by 99.82% to $37,000 in 2024.